A number of firms have modified their ratings and price targets on shares of MediaAlpha (NYSE: MAX) recently: 10/31/2026 – MediaAlpha was downgraded by Wall Street Zen from “strong-buy” to “buy”. 10/29/2026 – MediaAlpha had its price target raised by Royal Bank Of Canada from $15.00 to $17.00. They now have an “outperform” rating on […]

Ovintiv (NYSE: OVV) has recently received a number of price target changes and ratings updates: 11/5/2026 – Ovintiv had its price target raised by Truist Financial from $77.00 to $90.00. They now have a “buy” rating on the stock. 11/5/2026 – Ovintiv had its price target lowered by Wells Fargo & Company from $82.00 to […]

A number of research firms have changed their ratings and price targets for GXO Logistics (NYSE: GXO): 11/5/2026 – GXO Logistics had its “buy” rating reaffirmed by The Goldman Sachs Group. They now have a $66.00 price target on the stock. 11/5/2026 – GXO Logistics had its price target raised by UBS Group from $64.00 […]

A number of research firms have changed their ratings and price targets for AtriCure (NASDAQ: ATRC): 11/4/2026 – AtriCure had its price target raised by BTIG Research from $63.00 to $70.00. They now have a “buy” rating on the stock. 11/4/2026 – AtriCure was upgraded by Zacks Research from “hold” to “strong-buy”. 11/4/2026 – AtriCure […]

A number of research firms have changed their ratings and price targets for Revolution Medicines (NASDAQ: RVMD): 11/6/2026 – Revolution Medicines had its price target raised by HC Wainwright from $280.00 to $350.00. They now have a “buy” rating on the stock. 11/5/2026 – Revolution Medicines had its price target raised by TD Cowen from […]

Several brokerages have updated their recommendations and price targets on shares of M&T Bank (NYSE: MTB) in the last few weeks: 10/27/2026 – M&T Bank was downgraded by Wolfe Research from “peer perform” to “underperform”. They now have a $198.00 price target on the stock. 10/21/2026 – M&T Bank had its price target raised by […]

Several analysts have recently updated their ratings and price targets for Las Vegas Sands (NYSE: LVS): 11/3/2026 – Las Vegas Sands was downgraded by Zacks Research from “hold” to “strong sell”. 10/22/2026 – Las Vegas Sands was given a new $47.00 price target by Susquehanna. 10/22/2026 – Las Vegas Sands had its price target lowered […]

A number of firms have modified their ratings and price targets on shares of Boise Cascade (NYSE: BCC) recently: 11/5/2026 – Boise Cascade was downgraded by BMO Capital Markets from “outperform” to “market perform”. They now have a $88.00 price target on the stock, down from $100.00. 11/4/2026 – Boise Cascade had its price target […]

Several analysts have recently updated their ratings and price targets for Urogen Pharma (NASDAQ: URGN): 11/5/2026 – Urogen Pharma was given a new $60.00 price target by Oppenheimer. 11/5/2026 – Urogen Pharma had its “outperform” rating reaffirmed by UBS Group. 11/5/2026 – Urogen Pharma had its price target lowered by Guggenheim from $58.00 to $56.00. […]